SCHEMBL8563632

SCHEMBL8563632

Nc1ccc(Sc2ccc3ccccc3c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.61
MAPK1 P28482 2/20 0.61
TSHR P16473 1/20 0.61
ALDH1A1 P00352 2/20 0.60
HSD17B10 Q99714 2/20 0.60
LMNA P02545 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
ALOX15 P16050 1/20 0.52
CASP1 P29466 1/20 0.52
CASP7 P55210 1/20 0.52
HBB P68871 1/20 0.52
HIF1A Q16665 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
ANXA2 P07355 1/20 0.50
S100A10 P60903 1/20 0.50
MAPT P10636 3/20 0.47
KDM1A O60341 1/20 0.47
MAP2K2 P36507 2/20 0.46
MAP2K1 Q02750 2/20 0.46
SIRT2 Q8IXJ6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL761802 0.86 LMNA (0.57) CYP3A4MAPK1ALDH1A1HSD17B10LMNA
SCHEMBL30832956 0.86 LMNA (0.57) CYP3A4MAPK1ALDH1A1HSD17B10LMNA
SCHEMBL3281214 0.84 LMNA (0.52) CYP3A4MAPK1ALDH1A1HSD17B10LMNA
SCHEMBL1100970 0.79 CYP3A4 (0.70) CYP3A4MAPK1TSHRALDH1A1SMN1; SMN2
SCHEMBL11300299 0.79 ALDH1A1 (0.50) CYP3A4MAPK1ALDH1A1HSD17B10LMNA
SCHEMBL202221 0.79 CYP3A4 (0.78) CYP3A4MAPK1TSHRALDH1A1HSD17B10
SCHEMBL14176682 0.78 CYP2A6 (0.60) CYP3A4MAPK1TSHRALDH1A1HSD17B10
SCHEMBL8514752 0.78 LMNA (0.47) MAPK1ALDH1A1HSD17B10LMNASMN1; SMN2
SCHEMBL12952450 0.78 LMNA (0.47) CYP3A4MAPK1ALDH1A1HSD17B10LMNA
4,4'-Thiodianiline SCHEMBL28778309 0.78 CYP3A4 (0.88) CYP3A4MAPK1TSHRALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5814646-A TREATING THE PROGRESSION OF ALZHEIMER'S DISEASE, BRAIN DISORDERS ELI LILLY AND COMPANY (US) 1998-09-29 US disclosed
US-5624937-A TREATMENT OF ALZHEIMER'S DISEASE ELI LILLY AND COMPANY (US) 1997-04-29 US disclosed
US-4072696-A 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity SYNTEX (U.S.A.) INC. (US) 1978-02-07 US disclosed